| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
STOMACH |
1 Department of Medical Gastroenterology, Odense University Hospital, Denmark
2 Department of Internal Medicine, Odense University Hospital. Denmark
Correspondence to:
Correspondence to:
Dr A T Lassen
Department of Medical Gastroenterology, Odense University Hospital, 5000 Odense C, Denmark; Annmarie.lassen{at}ouh.fyns-amt.dk
Background: Dyspepsia is a chronic disease with significant impact on the use of health care resources. A management strategy based on Helicobacter pylori testing has been recommended but the long term effect is unknown.
Aim: To investigate the long term effect of a test and treat strategy compared with prompt endoscopy for management of dyspeptic patients in primary care.
Patients: A total of 500 patients presenting in primary care with dyspepsia were randomised to management by H pylori testing plus eradication therapy (n = 250) or by endoscopy (n = 250). Results of 12 month follow up have previously been presented.
Methods: Symptoms, quality of life, and patient satisfaction were recorded during a three month period, a median 6.7 years after randomisation (range 6.1–7.3 years). Number of endoscopies, antisecretory medication, H pylori treatments, and hospital visits were recorded from health care databases for the entire follow up period.
Results: Median age was 45 years; 28% were H pylori infected. Use of resources was registered in all 500 patients (3084 person years) of whom 312 completed diaries. We found no difference in symptoms between the two groups. Median proportion of days without symptoms was 0.52 (interquartile range 0.10–0.88) in the test and eradicate group versus 0.64 (0.14–0.90) in the prompt endoscopy group (p = 0.27) (mean difference 0.05 (95% confidence interval (CI) –0.03 to 0.14)). Compared with the prompt endoscopy group, the test and eradicate group underwent fewer endoscopies (mean difference 0.62 endoscopies/person (95% CI 0.38–0.86)) and used less antisecretory medication (mean difference 102 defined daily doses/person (95% CI –1 to 205)).
Conclusion: On a long term basis, a H pylori test and eradicate strategy is as efficient as prompt endoscopy for management of dyspeptic patients in primary care and reduces the use of endoscopy and antisecretory medication.
Abbreviations: NSAID, non-steroidal-anti-inflammatory drug; DDD, defined daily doses; PPI, proton pump inhibitor
Keywords: dyspepsia; endoscopy; Helicobacter pylori; randomised controlled trial
Relevant Article
Gut 2004 53: 1723.
This article has been cited by other articles:
|
|
 |
|
  S Mahadeva, Y-C Chia, A Vinothini, M Mohazmi, and K-L Goh Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia Gut, September 1, 2008; 57(9): 1214 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Gatta, C Ricci, A Tampieri, J Osborn, F Perna, V Bernabucci, and D Vaira Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial Gut, April 1, 2006; 55(4): 457 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Test and eradicate is best for dyspepsia after six years BMJ, May 14, 2005; 330(7500): . [Full Text] [PDF]
|
|
|
|
|
|
H. Marcovitch What's new this month in BMJ Journals BMJ, January 15, 2005; 330(7483): 116 - 116. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
